%0 Journal Article
%A Bermejo, Justo L
%A Huang, Guanmengqian
%A Manoochehri, Mehdi
%A Mesa, Karen G
%A Schick, Matthias
%A Silos, Rosa G
%A Ko, Yon-Dschun
%A Brüning, Thomas
%A Brauch, Hiltrud
%A Lo, Wing-Yee
%A Hoheisel, Jörg
%A Hamann, Ute
%T Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer.
%J Epigenomics
%V 11
%N 1
%@ 1750-192X
%C London
%I Future Medicine Ltd.
%M DKFZ-2018-01518
%P 81-93
%D 2019
%X To identify DNA methylation biomarkers in peripheral blood samples from triple-negative breast cancer (TNBC) patients.We conducted an epigenome-wide association study (EWAS): the most promising markers were identified in 233 TNBC case-control pairs (discovery set) and subsequently validated in an independent validation set (57 TNBC patients and 124 controls).cg06588802 (LINC00299/ID2) showed a higher methylation in TNBC patients compared with controls (discovery set: 3
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:30208740
%R 10.2217/epi-2018-0121
%U https://inrepo02.dkfz.de/record/137638